{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-26-000221","form_type":"8-K","ticker":"ARTL","cik":"0001621221","company_name":"ARTELO BIOSCIENCES, INC.","filed_at":"2026-02-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.661542+00:00","generated_at":"2026-05-16T04:27:26.991637+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Artelo Biosciences gets Nasdaq panel exception to cure listing deficiencies by March 30","bullets":["Panel granted exception to regain compliance with $2.5M stockholders' equity rule by March 30, 2026.","Company held 2025 annual meeting on Jan 30, curing annual meeting rule deficiency previously cited by Nasdaq.","Company previously received delist determination in Nov 2025; hearing stayed action.","Company intends to take all reasonable measures to regain compliance, but no assurance of success.","Failure to demonstrate compliance by March 30 could result in delisting from Nasdaq."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-26-000221","json":"https://secwatch.observer/filing/0001640334-26-000221.json","markdown":"https://secwatch.observer/filing/0001640334-26-000221.md","text":"https://secwatch.observer/filing/0001640334-26-000221.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1621221/000164033426000221/0001640334-26-000221-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1621221/000164033426000221/artl_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T04:27:26.991637+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}